Overview

A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Subjects

Status:
NOT_YET_RECRUITING

Trial end date:
2024-06-01

Target enrollment:

Participant gender:

Summary

This study is a single-center, open-lable and fixed sequence test conducted in healthy subjects to evaluate the pharmacokinetic effects of Itraconazole and Rifampicin on a single dose of SY-5007 Oral administration. It is planned to enroll 28 healthy subjects and assign them to two parallel test groups, Group A (SY-5007 combined with Itraconazole) and Group B (SY-5007 combined with Rifampicin).

Phase:

PHASE1

Details

Lead Sponsor:

Shouyao Holdings (Beijing) Co. LTD

Treatments:

Itraconazole
Rifampin